Er Craneware udbyttet sikkert?
Craneware har øget udbyttet i 1 år.
Inden for de seneste 10 år har Craneware øget denne med 7,640 % årligt forøget.
På 5-årssigt steg udbetalingen med 2,208 %.
Analytikerne forventer en Dividendeøgning på 0,107% for det igangværende regnskabsår.
Craneware Aktienanalyse
Hvad laver Craneware?
Craneware PLC is a publicly traded company based in Edinburgh, Scotland, that specializes in the development and marketing of software solutions for the healthcare industry. The company was founded in 1999 and has been listed on the London Stock Exchange since 2007.
The business model of Craneware is based on the development and marketing of software solutions for the healthcare industry that help customers optimize their financial and performance processes. Craneware focuses particularly on the area of Revenue Cycle Management (RCM), which involves the management of hospital billing and payment processes.
Craneware's software solutions are used in various areas, including billing, pricing, contract management, compliance, and analytics. The products are modular and can be individually configured according to the customer's needs.
One example of a product is the Revenue Integrity Management System (RIMS), which allows for comprehensive analysis of patient billing and ensures that hospitals maximize their revenue while complying with regulations.
Other products include Reference Plus, which helps customers determine and stay competitive with pricing for medical services, and the Online Analytics Suite, which specializes in data analysis and reporting.
Craneware is divided into different divisions, including North America, International, and UK & EMEA. North America is the largest market for the company, accounting for approximately 90% of its revenue.
In North America, Craneware has a strong presence and works closely with many large hospitals and healthcare organizations. The company's focus on RCM solutions has received significant attention, and many customers appreciate the efficiency and effectiveness of the software solutions.
In the International division, Craneware focuses on expanding its presence in Europe, Asia, Africa, and the Middle East. The company has already gained many partners in these regions and is working to further expand its market share.
In the UK & EMEA division, Craneware primarily serves NHS hospitals (National Health Service) and offers a wide range of RCM solutions to its customers.
Craneware was founded in 1999 by Edinburgh University graduate Gordon Craig. The company's headquarters were established in Edinburgh and quickly became a major employer in the city.
In 2007, Craneware was listed on the London Stock Exchange and has since been a publicly traded company. In 2015, the company was included in the FTSE AIM 100 Index.
In recent years, Craneware has experienced strong growth and expanded its market presence to different countries. The company plans to continue investing in research and development and focusing on innovation to provide its customers with the best RCM solutions in the future. Craneware er et af de mest populære virksomheder på Eulerpool.com.Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.